KFS
IART icon

Kelly Financial Services’s Integra LifeSciences IART Stock Holding History

Kelly Financial Services’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-17
Closed -$495 – 379
2024
Q2 		$495 Hold
17
– – ﹤0.01% 705
2024
Q1 		$603 Hold
17
– – ﹤0.01% 707
2023
Q4 		$740 Hold
17
– – ﹤0.01% 677
2023
Q3 		$649 Hold
17
– – ﹤0.01% 665
2023
Q2 		$699 Hold
17
– – ﹤0.01% 631
2023
Q1 		$976 Hold
17
– – ﹤0.01% 593
2022
Q4 		$953 Hold
17
– – ﹤0.01% 570
2022
Q3 		$720 Hold
17
– – ﹤0.01% 591
2022
Q2 		$919 Buy
+17
New +$1.02K ﹤0.01% 565

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Kelly Financial Services's IART Position: Q3 2024 in Review

Kelly Financial Services sold out of Integra LifeSciences (IART) in Q3 2024, closing a stake of 17 shares — an estimated $495 sold.

Kelly Financial Services first reported a position in IART in Q2 2022 and held it in 9 quarters. The position peaked at $976 in Q1 2023. 225 funds tracked by Wall St. Rank hold IART as of Q3 2024.

  • Kelly Financial Services reported no remaining Integra LifeSciences position as of Q3 2024 after selling out during the quarter.
  • Kelly Financial Services sold 17 Integra LifeSciences shares in Q3 2024, an estimated $495.
  • Kelly Financial Services first reported a position in Integra LifeSciences in Q2 2022 and held it in 9 quarters.
  • Kelly Financial Services's Integra LifeSciences position peaked at $976 in Q1 2023.
  • 225 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2024.

Based on Kelly Financial Services's 13F filing for Q3 2024, filed 9 Oct 2024.